Nevro (NVRO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Nevro Revenue Highlights

Latest Revenue (Y)

$408.52M

Latest Revenue (Q)

$104.16M

Main Segment (Y)

Reportable Segment

Main Geography (Y)

UNITED STATES

Nevro Revenue by Period

Nevro Revenue by Year

Date	Revenue	Change
2024-12-31	$408.52M	-3.92%
2023-12-31	$425.17M	4.63%
2022-12-31	$406.37M	5.03%
2021-12-31	$386.90M	6.87%
2020-12-31	$362.05M	-7.23%
2019-12-31	$390.25M	0.77%
2018-12-31	$387.29M	18.56%
2017-12-31	$326.67M	42.96%
2016-12-31	$228.50M	228.28%
2015-12-31	$69.61M	113.69%
2014-12-31	$32.57M	38.61%
2013-12-31	$23.50M	29.48%
2012-12-31	$18.15M	-

Nevro generated $408.52M in revenue during NA 2024, up -3.92% compared to the previous quarter, and up 104.68% compared to the same period a year ago.

Nevro Revenue by Quarter

Date	Revenue	Change
2024-06-30	$104.16M	2.22%
2024-03-31	$101.90M	-12.29%
2023-12-31	$116.18M	11.86%
2023-09-30	$103.86M	-4.55%
2023-06-30	$108.81M	12.96%
2023-03-31	$96.33M	-15.39%
2022-12-31	$113.84M	13.32%
2022-09-30	$100.47M	-3.60%
2022-06-30	$104.21M	18.64%
2022-03-31	$87.84M	-14.52%
2021-12-31	$102.76M	10.25%
2021-09-30	$93.20M	-8.92%
2021-06-30	$102.33M	15.48%
2021-03-31	$88.61M	-19.25%
2020-12-31	$109.73M	1.17%
2020-09-30	$108.46M	92.34%
2020-06-30	$56.39M	-35.53%
2020-03-31	$87.47M	-23.53%
2019-12-31	$114.37M	14.19%
2019-09-30	$100.16M	7.04%
2019-06-30	$93.57M	13.91%
2019-03-31	$82.15M	-23.90%
2018-12-31	$107.94M	12.88%
2018-09-30	$95.63M	-0.47%
2018-06-30	$96.08M	9.64%
2018-03-31	$87.64M	-10.54%
2017-12-31	$97.96M	19.10%
2017-09-30	$82.26M	5.43%
2017-06-30	$78.02M	13.99%
2017-03-31	$68.44M	-2.97%
2016-12-31	$70.53M	15.77%
2016-09-30	$60.92M	9.97%
2016-06-30	$55.40M	33.01%
2016-03-31	$41.65M	25.74%
2015-12-31	$33.12M	115.06%
2015-09-30	$15.40M	34.89%
2015-06-30	$11.42M	18.17%
2015-03-31	$9.66M	-0.55%
2014-12-31	$9.71M	12.08%
2014-09-30	$8.67M	15.17%
2014-06-30	$7.53M	12.94%
2014-03-31	$6.66M	7.55%
2013-12-31	$6.20M	-0.03%
2013-09-30	$6.20M	-

Nevro generated $104.16M in revenue during Q2 2024, up 2.22% compared to the previous quarter, and up 108.13% compared to the same period a year ago.

Nevro Revenue Breakdown

Nevro Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21
Reportable Segment	$408.52M	-	-	-
Painful Diabetic Neuropathy	-	$77.90M	$48.00M	$5.70M

Nevro's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Sep 21
Painful Diabetic Neuropathy	$22.50M	$20.80M	$19.00M	$15.60M	$17.60M	$13.40M	$11.00M	$6.00M	$1.70M

Nevro's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Painful Diabetic Neuropathy (100.00%).

Nevro Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Non-US	$55.44M	$58.62M	$58.20M	-	-
UNITED STATES	$353.08M	$366.56M	$348.17M	$326.22M	$311.87M
Non Us	-	-	-	$60.69M	$50.17M

Nevro's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (86.43%), and Non-US (13.57%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 18	Sep 18	Jun 18	Mar 18
Non-US	$27.57M	$13.01M	$14.86M	$14.66M	$14.10M	$15.85M	$14.01M	$14.07M	$14.34M	$15.16M	-	-	-	-	-
UNITED STATES	$182.14M	$83.90M	$87.04M	$101.52M	$89.76M	$92.96M	$82.32M	$99.77M	$86.13M	$89.05M	$73.21M	$91.62M	$79.62M	$79.91M	$70.62M
Non Us	-	-	-	-	-	-	-	-	-	-	$14.63M	$16.32M	$16.01M	$16.17M	$17.01M

Nevro's latest quarterly revenue breakdown by geography, as of Dec 24: UNITED STATES (86.85%), and Non-US (13.15%).

Nevro Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ITGR	Integer	$1.72B	$746.27M
CNMD	CONMED	$1.31B	$316.70M
LIVN	LivaNova	$1.25B	$318.11M
NVRO	Nevro	$408.52M	$104.16M
GKOS	Glaukos	$383.48M	$96.67M
FNA	Paragon 28	$256.18M	$61.02M
KIDS	OrthoPediatrics	$204.73M	$52.80M
RXST	RxSight	$139.93M	$45.41M
SRDX	Surmodics	$126.08M	$29.92M
LUNG	Pulmonx	$83.79M	$20.39M
NPCE	NeuroPace	$79.91M	$21.06M
SGHT	Sight Sciences	$79.87M	$20.16M
IRMD	IRadimed	$73.24M	$18.33M
CVRX	CVRx	$51.29M	$13.37M
OFIX	Orthofix Medical	-	$198.62M

NVRO Revenue FAQ

What is Nevro’s yearly revenue?

Nevro's yearly revenue for 2024 was $408.52M, representing a decrease of -3.92% compared to 2023. The company's yearly revenue for 2023 was $425.17M, representing an increase of 4.63% compared to 2022. NVRO's yearly revenue for 2022 was $406.36M, representing an increase of 5.03% compared to 2021.

What is Nevro’s quarterly revenue?

Nevro's quarterly revenue for Q2 2024 was $104.16M, a 2.22% increase from the previous quarter (Q1 2024), and a -4.27% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $101.9M, a -12.29% decrease from the previous quarter (Q4 2023), and a 5.78% increase year-over-year (Q1 2023). NVRO's quarterly revenue for Q4 2023 was $116.18M, a 11.86% increase from the previous quarter (Q3 2023), and a 2.05% increase year-over-year (Q4 2022).

What is Nevro’s revenue growth rate?

Nevro's revenue growth rate for the last 3 years (2022-2024) was 0.53%, and for the last 5 years (2020-2024) was 12.84%.

What are Nevro’s revenue streams?

Nevro's revenue streams in c 24 are Reportable Segment

What is Nevro’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Nevro was Reportable Segment. This segment made a revenue of $408.52M, representing 100.00% of the company's total revenue.